Učitavanje...
A111 INFLIXIMAB FOR INDUCTION OF REMISSION IN CROHN’S DISEASE
BACKGROUND: Crohn’s disease (CD) is a chronic idiopathic disease characterized by transmural inflammation of the gastrointestinal tract. AIMS: To evaluate the efficacy and safety of infliximab (IFX) for induction of remission in CD. METHODS: MEDLINE, EMBASE, the Cochrane Library were searched from d...
Spremljeno u:
| Izdano u: | J Can Assoc Gastroenterol |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507942/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.112 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|